Latest Articles

Article Type

Open Access
α6-Containing GABA_A Receptors: Functional Roles and Therapeutic Potentials
Werner Sieghart, Lih-Chu Chiou, Margot Ernst, Jure Fabjan, Miroslav M. Savić and Ming Tatt Lee
Charles France, ASSOCIATE EDITOR

Pharmacological Reviews January 2022, 74 (1) 238-270; DOI: https://doi.org/10.1124/pharmrev.121.000293
Open Access
Neurobiological Mechanisms of Nicotine Reward and Aversion
Lauren Wills, Jessica L. Ables, Kevin M. Braunscheidel, Stephanie P.B. Caligiuri, Karim S. Elayouby, Clementine Fillinger, Masago Ishikawa, Janna K. Moen and Paul J. Kenny
Charles France, ASSOCIATE EDITOR

Pharmacological Reviews January 2022, 74 (1) 271-310; DOI: https://doi.org/10.1124/pharmrev.121.000299
Open Access
Organotypic and Microphysiological Human Tissue Models for Drug Discovery and Development—Current State-of-the-Art and Future Perspectives
Sonia Youhanna, Aurino M. Kemas, Lena Preiss, Yitian Zhou, Joanne X. Shen, Selgin D. Cakal, Francesco S. Paqualini, Sravan K. Goparaju, Reza Zandi Shafagh, Johan Ulrik Lind, Carl M. Sellgren and Volker M. Lauschke
Gunnar Schulte, ASSOCIATE EDITOR

Pharmacological Reviews January 2022, 74 (1) 141-206; DOI: https://doi.org/10.1124/pharmrev.120.000238
Open Access
Inhaled Medicines: Past, Present, and Future
Sandra Anderson, Paul Atkins, Per Bäckman, David Cipolla, Andrew Clark, Evangelia Daviskas, Bernd Disse, Plamena Entcheva-Dimitrov, Rick Fuller, Igor Gonda, Hans Lundbäck, Bo Olsson and Jeffry Weers
Clive Page, ASSOCIATE EDITOR

Pharmacological Reviews January 2022, 74 (1) 48-118; DOI: https://doi.org/10.1124/pharmrev.120.000108
Open Access
The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein
Lauren M. Lucas, Vipasha Dwivedi, Jared I. Senfeld, Richard L. Cullum, Christopher P. Mill, J. Tyler Piazza, Ianthe N. Bryant, Laura J. Cook, S. Tyler Miller, James H. Lott, Connor M. Kelley, Elizabeth L. Knerr, Jessica A. Markham, David P. Kaufmann, Megan A. Jacobi, Jianzhong Shen and David J. Riese
Eric Barker, ASSOCIATE EDITOR

Pharmacological Reviews January 2022, 74 (1) 18-47; DOI: https://doi.org/10.1124/pharmrev.121.000381
You have access
Targeting Systemic Innate Immune Cells as a Therapeutic Avenue for Alzheimer Disease
Vincent Pons and Serge Rivest
Robert Dantzer, ASSOCIATE EDITOR

Pharmacological Reviews January 2022, 74 (1) 1-17; DOI: https://doi.org/10.1124/pharmrev.121.000400
You have access
Sex Differences in Opioid and Psychostimulant Craving and Relapse: A Critical Review
Céline Nicolas, Natalie E. Zlebnik, Mehdi Farokhnia, Lorenzo Leggio, Satoshi Ikemoto and Yavin Shaham
Michael Nader, ASSOCIATE EDITOR

Pharmacological Reviews January 2022, 74 (1) 119-140; DOI: https://doi.org/10.1124/pharmrev.121.000367
Open Access
Aldo-Keto Reductases and Cancer Drug Resistance
Trevor M. Penning, Sravan Jonnalagadda, Paul C. Trippier and Tea Lanišnik Rižner
Michael Gottesman, ASSOCIATE EDITOR

Pharmacological Reviews July 2021, 73 (3) 1150-1171; DOI: https://doi.org/10.1124/pharmrev.120.000122
You have access
Therapeutic Targeting of α7 Nicotinic Acetylcholine Receptors
Roger L. Papke and Nicole A. Horenstein
Habibeh Khoshbouei, ASSOCIATE EDITOR

Pharmacological Reviews July 2021, 73 (3) 1118-1149; DOI: https://doi.org/10.1124/pharmrev.120.000097
You have access
Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
Michael J. Lucido, Mandy Bekhbat, David R. Goldsmith, Michael T. Treadway, Ebrahim Haroon, Jennifer C. Felger and Andrew H. Miller
Robert Dantzer, ASSOCIATE EDITOR

Pharmacological Reviews July 2021, 73 (3) 1084-1117; DOI: https://doi.org/10.1124/pharmrev.120.000043

Main menu

User menu

Search

Latest Articles

Pages

Navigate

More Information

ASPET's Other Journals